Inventor · disambiguated record
Xu Bai
Also filed as: BAI XU
11 granted patents·3 pending applications·224 citations·filing 1996–2015
91Inventor score
Files withIDUN PHARMACEUTICALS INC10BRISTOL MYERS SQUIBB PHARMA CO1GUANGZHOU BERYL THERAPEUTICS INC1
Top patents by PatentIndex Score
14 records- 0189US6200969B1Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 1997·Granted Mar 13, 2001·38 cites·23 claims
- 0283US6184244B1C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 1999·Granted Feb 6, 2001·46 cites·15 claims
- 0381US6693096B2Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2002·Granted Feb 17, 2004·11 cites·18 claims
- 0479US5869519AC-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 1996·Granted Feb 9, 1999·56 cites·59 claims
- 0578US5877197AC-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesFiled 1997·Granted Mar 2, 1999·56 cites·49 claims
- 0672US6610683B2Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2001·Granted Aug 26, 2003·4 cites·9 claims
- 0772US6528506B2Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2002·Granted Mar 4, 2003·4 cites·7 claims
- 0870US6531467B2Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2001·Granted Mar 11, 2003·5 cites·77 claims
- 0964US6489353B2C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Dec 3, 2002·1 cites·41 claims
- 1063US6825208B2Tetrahydroquinoline derivatives as antithrombotic agentsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 30, 2004·3 cites·37 claims
- 1153US2004058850A1Treatment of kidney disease or renal failure using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 1251US2003119748A1C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1348US2001044415A1Inhibition of apoptosis using interleukin-1B-converting enzyme (ICE)/CED-3 family inhibitorsFiled 2001·Application pending·0 cites
- 1422US10072035B2Phenanthroline phosphonic acid derivative and preparation method therefor and application thereofGUANGZHOU BERYL THERAPEUTICS INC·Filed 2015·Granted Sep 11, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Xu Bai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →